Search
08/02/2023
Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
Rusinol, L, Puig, L. Tyk2 Targeting in Immune-Mediated Inflammatory Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(4)DOI:10.3390/ijms24043391. PMID:36834806. IF:4.900(Q1/3D).
01/02/2023
Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease
Garcia-Forn, M, Castany-Pladevall, C, Golbano, A, Perez-Perez, J, Brito, V, Kulisevsky, J, Perez-Navarro, E. Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease. Clinical and Translational Medicine. 2023; 13(2)DOI:10.1002/ctm2.1154. PMID:36781300. IF:7.900(Q1/1D).
01/02/2023
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Pagonabarraga, J, Alamo, C, Castellanos, M, Diaz, S, Manzano, S. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences. 2023; 13(2)DOI:10.3390/brainsci13020318. PMID:36831861. IF:2.700(Q3/6D).
01/02/2023
The role of opioid transmission in music-induced pleasure
Mas-Herrero, E, Ferreri, L, Cardona, G, Zatorre, RJ, Pla-Junca, F, Antonijoan, RM, Riba, J, Valle, M, Rodriguez-Fornells, A. The role of opioid transmission in music-induced pleasure. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2023; 1520(1)DOI:10.1111/nyas.14946. PMID:36514207. IF:4.100(Q1/2D).
01/02/2023
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
Sanchez-Torres, AM, Amoretti, S, Enguita-German, M, Mezquida, G, Moreno-Izco, L, Panadero-Gomez, R, Rementeria, L, Toll, A, Rodriguez-Jimenez, R, Roldan, A, Pomarol-Clotet, E, Ibanez, A, Usall, J, Contreras, F, Vieta, E, Lopez-Ilundain, JM, Merchan-Naranjo, J, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Cuesta, MJ. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 67DOI:10.1016/j.euroneuro.2022.11.011. PMID:36495858. IF:6.100(Q1/1D).
01/02/2023
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
Ariceta, G, Collard, L, Abroug, S, Moochhala, SH, Gould, E, Boussetta, A, Ben Hmida, M, De, S, Hunley, TE, Jarraya, F, Fraga, G, Banos, A, Lindner, E, Dehmel, B, Schalk, G. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. PEDIATRIC NEPHROLOGY. 2023; 38(2)DOI:10.1007/s00467-022-05591-5. PMID:35552824. IF:2.600(Q1/3D).
01/02/2023
Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial
Gomis-Pastor, M, Perez, SM, Lopez, AD, Loidi, VB, Lopez, LL, Cruz, RP, Bafalluy, MAM. Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial. Journal of Cardiovascular Development and Disease. 2023; 10(2)DOI:10.3390/jcdd10020077. PMID:36826572. IF:2.400(Q2/5D).
01/02/2023
European training in urology (ENTRY): quality-assured training for European urology residents
Buffi, N, Paciotti, M, Gallagher, AG, Diana, P, De Groote, R, Lughezzani, G, Gallioli, A, Casale, P, Palou, J, Mottrie, A, Breda, A. European training in urology (ENTRY): quality-assured training for European urology residents. BJU INTERNATIONAL. 2023; 131(2)DOI:10.1111/bju.15928. PMID:36337002. IF:3.700(Q1/2D).